Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
2.
Pediatr Dermatol ; 41(1): 84-86, 2024.
Article in English | MEDLINE | ID: mdl-37317663

ABSTRACT

Reactive infectious mucocutaneous eruption (RIME) is an eruptive mucositis with varying degrees of cutaneous involvement presumed to be due to an immunologic response to various infectious pathogens. Most reported cases occur after a prodromal upper respiratory illness. We present a patient with a particularly severe case mimicking drug-induced epidermal necrolysis found to be triggered by asymptomatic norovirus infection, a virus not previously reported in association with RIME.


Subject(s)
Mucositis , Norovirus , Stevens-Johnson Syndrome , Humans , Stevens-Johnson Syndrome/etiology , Stevens-Johnson Syndrome/complications , Mucositis/complications
3.
Pediatr Dermatol ; 41(1): 28-33, 2024.
Article in English | MEDLINE | ID: mdl-38018236

ABSTRACT

BACKGROUND/OBJECTIVES: There is a paucity of pediatric hidradenitis suppurativa (HS) literature. The objective of this study was to characterize differences in management of pediatric HS patients by dermatology versus non-dermatology clinicians. METHODS: We examined a retrospective cohort of 195 pediatric patients with HS seen at our institution (3/1/19-3/1/20). Two-sample t-tests and two-proportion z-tests were performed. RESULTS: A total of 76.1% of subjects were seen by dermatology at least once, and of these, 79.1% were referred. HS diagnosis was most often made by dermatology (36.6%), followed by pediatrics (21.6%). Patients managed by dermatology were significantly more likely to have used standard of care therapies (p < .001). Of dermatology-managed patients, 19.7% were currently prescribed a biologic, as compared with zero patients not managed by dermatology. Those managed by dermatology were less likely to undergo surgical excision (13.3% vs. 25.5%, p = .04). CONCLUSIONS: Our results support increased likelihood of treatment escalation with medical management by dermatologists. Relatively high utilization of referral to dermatology exists, but with only moderate patient adherence. There is a need for improved access to dermatologic care and prospective studies to determine whether differences in specialty management translate to improved patient outcomes.


Subject(s)
Hidradenitis Suppurativa , Humans , Child , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/therapy , Retrospective Studies , Prospective Studies , Patient Compliance
4.
Paediatr Drugs ; 25(4): 459-466, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37225932

ABSTRACT

BACKGROUND: Chronic hand eczema (CHE) significantly impacts quality of life. Published literature on pediatric CHE (P-CHE) in North America including knowledge on epidemiology and standard evaluation and management is limited. OBJECTIVE: Our objective was to assess diagnostic practices when evaluating patients with P-CHE in the US and Canada, produce data on therapeutic agent prescribing practices for the disorder, and lay the foundation for future studies. METHODS: We surveyed pediatric dermatologists to collect data on clinician and patient population demographics, diagnostic methods, therapeutic agent selection, among other statistics. From June 2021 to January 2022, a survey was distributed to members of the Pediatric Dermatology Research Alliance (PeDRA). RESULTS: Fifty PeDRA members responded stating that they would be interested in participating, and 21 surveys were completed. For patients with P-CHE, providers most often utilize the diagnoses of irritant contact dermatitis, allergic contact dermatitis, dyshidrotic hand eczema, and atopic dermatitis. Contact allergy patch testing and bacterial hand culture are the most used tests for workup. Nearly all utilize topical corticosteroids as first line therapy. Most responders report that they have treated fewer than six patients with systemic agents and prefer dupilumab as first-line systemic therapy. CONCLUSIONS: This is the first characterization of P-CHE among pediatric dermatologists in the United States and Canada. This assessment may prove useful in designing further investigations including prospective studies of P-CHE epidemiology, morphology, nomenclature, and management.


Subject(s)
Dermatitis, Atopic , Dermatology , Eczema , Humans , Child , United States , Prospective Studies , Quality of Life , Eczema/diagnosis , Eczema/drug therapy , Eczema/epidemiology , Dermatitis, Atopic/drug therapy
5.
Pediatrics ; 151(5)2023 05 01.
Article in English | MEDLINE | ID: mdl-37102307

ABSTRACT

Hidradenitis suppurativa is a chronic inflammatory skin disorder primarily affecting apocrine gland-bearing areas, including the axillae, groin, and buttocks. It is reported in up to 2% of Western populations and with increasing incidence in children and adults. Nearly one-third of hidradenitis suppurativa cases occur in pediatric patients and nearly half of patients endorse initial symptoms in childhood. To date, there are few clinical studies and guidelines for pediatric hidradenitis suppurativa. Here, we review the epidemiology, clinical presentation, comorbidities, and management of pediatric hidradenitis suppurativa. We discuss barriers contributing to delays in diagnosis and the significant physical and emotional impact of the disease on children and adolescents.


Subject(s)
Hidradenitis Suppurativa , Adult , Humans , Child , Adolescent , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/epidemiology , Hidradenitis Suppurativa/therapy , Comorbidity , Groin , Pelvis
6.
Neoreviews ; 24(3): e175-e180, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36854848

ABSTRACT

Congenital cutaneous candidiasis (CCC) is a rare condition, which typically affects premature and very low birthweight neonates. Affected infants present with a diffuse rash of variable morphology, which can appear as peeling, sloughing desquamation; maculopapular lesions; or, less commonly, pustules, vesicles, or bullae. Due to the varied nature of the clinical presentation, the diagnosis of CCC can be quite difficult but critically important because early treatment with intravenous fluconazole can prevent disease progression. In this review, we summarize the epidemiology, pathogenesis, clinical presentation, evaluation, and management of CCC.


Subject(s)
Candidiasis , Fetal Diseases , Infant, Newborn, Diseases , Premature Birth , Infant , Female , Infant, Newborn , Humans , Infant, Premature , Infant, Very Low Birth Weight , Disease Progression , Candidiasis/diagnosis , Candidiasis/drug therapy , Candidiasis/epidemiology
7.
Pediatr Dermatol ; 40(5): 900-903, 2023.
Article in English | MEDLINE | ID: mdl-36813738

ABSTRACT

Congenital erosive and vesicular dermatosis (CEVD) is a rare skin condition that most commonly presents as erosive and vesicular lesions on the trunk and extremities in premature infants and heals with characteristic reticulated and supple scarring (RSS). The exact pathogenesis of CEVD is unknown and is typically a diagnosis of exclusion. We present the cases of two extremely premature neonates with Candida septicemia who were found to have diffuse, erythematous skin eruptions shortly after birth that ultimately healed with RSS. Through these cases, we highlight the importance of including fungal infection in the work-up of CEVD healing with RSS.


Subject(s)
Mycoses , Skin Abnormalities , Skin Diseases, Vesiculobullous , Infant , Infant, Newborn , Humans , Cicatrix/etiology , Wound Healing , Skin Diseases, Vesiculobullous/pathology , Skin/pathology , Skin Abnormalities/pathology , Mycoses/complications , Mycoses/pathology , Rare Diseases/complications , Rare Diseases/pathology
8.
Dermatol Clin ; 40(4): 393-400, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36243427

ABSTRACT

This article explores what is known regarding infantile hemangioma (IH) genetics. Despite a great deal of research on this topic, the relationship between IH genetics and pathogenesis has yet to be understood. This article also outlines the appropriate work-up and management of syndromes associated with specific presentations of IH.


Subject(s)
Hemangioma, Capillary , Hemangioma , Neurocutaneous Syndromes , Hemangioma/genetics , Humans , Infant , Neurocutaneous Syndromes/genetics , Neurocutaneous Syndromes/pathology
11.
JAMA Dermatol ; 2021 06 16.
Article in English | MEDLINE | ID: mdl-34132754

ABSTRACT

Importance: A 2010 prospective study of 108 infants estimated the incidence of PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome to be 31% in children with facial infantile hemangiomas (IHs) of at least 22 cm2. There is little evidence regarding the associations among IH characteristics, demographic characteristics, and risk of PHACE syndrome. Objectives: To evaluate demographic characteristics and comorbidities in a large cohort of patients at risk for PHACE syndrome and assess the clinical features of large head and neck IH that may be associated with a greater risk of a diagnosis of PHACE syndrome. Design, Setting, and Participants: This multicenter, retrospective cohort study assessed all patients with a facial, head, and/or neck IH who were evaluated for PHACE syndrome from August 1, 2009, to December 31, 2014, at 13 pediatric dermatology referral centers across North America. Data analysis was performed from June 15, 2017, to February 29, 2020. Main Outcomes and Measures: The main outcome was presence or absence of PHACE syndrome. Data included age at diagnosis, sex, patterns of IH presentation (including size, segment location, and depth), diagnostic procedures and results, and type and number of associated anomalies. Results: A total of 238 patients (mean [SD] age, 2.96 [4.71] months; 184 [77.3%] female) were included in the analysis; 106 (44.5%) met the criteria for definite (n = 98) or possible (n = 8) PHACE syndrome. A stepwise linear regression model found that a surface area of 25 cm2 or greater (odds ratio [OR] 2.99; 95% CI, 1.49-6.02) and involvement of 3 or more locations (OR, 17.96; 95% CI, 6.10-52.85) to be statistically significant risk factors for PHACE syndrome. Involvement of the parotid gland (OR, 0.39; 95% CI, 0.18-0.85) and segment S2 (OR, 0.38; 95% CI, 0.16-0.91) was associated with a lower risk. Race and ethnicity may also be associated with PHACE syndrome risk, although more studies are needed. Conclusions and Relevance: This cohort study further described factors associated with both a higher and lower risk of PHACE syndrome. The presence of multiple anatomical sites and large surface area were associated with greater risk, whereas S2 or parotid IHs were associated with lower, but still potential, risk. These findings can help in counseling families and decision-making regarding evaluation of infants with large head and neck IHs.

13.
Pediatr Dermatol ; 38(3): 643-646, 2021 May.
Article in English | MEDLINE | ID: mdl-33675085

ABSTRACT

We report two unrelated infants who presented with orolabial ulcerations as a presenting manifestation of neonatal lupus erythematosus (NLE). Subsequent positive anti-SSA/SSB titers confirmed the diagnosis. In both infants, the ulcerations were painless and spontaneously resolved. NLE should be included in the differential diagnosis of orolabial ulcerations in the newborn, especially since mothers of affected infants may be asymptomatic.


Subject(s)
Lupus Erythematosus, Cutaneous , Lupus Erythematosus, Systemic , Antibodies, Antinuclear , Diagnosis, Differential , Female , Humans , Infant , Infant, Newborn , Lupus Erythematosus, Cutaneous/diagnosis , Lupus Erythematosus, Cutaneous/drug therapy , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/congenital , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/drug therapy , Mothers
16.
Lasers Surg Med ; 53(7): 946-952, 2021 09.
Article in English | MEDLINE | ID: mdl-32956533

ABSTRACT

BACKGROUND AND OBJECTIVES: To date, there are no well-established guidelines regarding laser therapy for the treatment of cutaneous lesions in pediatric patients. We aim to ascertain the types of lasers commonly used, types of lesions treated, and factors that affect the selection of specific laser modalities in pediatric patients. STUDY DESIGN/MATERIALS AND METHODS: An anonymous online survey was distributed to healthcare providers who treat children with lasers through listservs of four major national and international dermatology and laser organizations. RESULTS: Outpatient office-based procedure rooms are the most common clinical setting for laser procedures (74.4%), and pulsed dye laser is the most commonly used laser (95.4%). Conditions routinely treated with lasers included port wine stains (95.4%), infantile hemangiomas (81.5%), other vascular lesions (81.5%), scars (77.7%), and hair (60.8%). 84.4% of respondents expressed concern about general anesthesia in patients <2 years old. Nevi of Ota is treated with laser more frequently (52.3%) than other pigmented lesions. LIMITATIONS: Limited generalizability of case examples to general conditions. CONCLUSIONS: Vascular lesions are the most common lesions treated with lasers in pediatric dermatology patients, and most providers are using these devices in the outpatient setting. Many providers are concerned about the effects of repeated general anesthesia in infants, and there appears to be a trend toward providing laser therapy in the outpatient setting without general anesthesia. Lasers Surg. Med. © 2020 Wiley Periodicals LLC.


Subject(s)
Dermatology , Laser Therapy , Lasers, Dye , Port-Wine Stain , Skin Neoplasms , Child , Child, Preschool , Humans , Infant , Lasers, Dye/therapeutic use , Port-Wine Stain/radiotherapy , Port-Wine Stain/surgery , Skin Neoplasms/surgery , Surveys and Questionnaires
17.
Pediatr Dermatol ; 37(1): 228-229, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31667886

ABSTRACT

A 7-year-old healthy boy presented with an asymptomatic smooth, firm red plaque on the cheek. Histopathology, immunostaining, molecular testing and imaging confirmed a diagnosis of a primary cutaneous marginal zone B-cell lymphoma. The lesion was treated with intralesional triamcinolone, with complete clinical resolution achieved within one year. Intralesional steroid injection is an effective first-line modality for the treatment of patients with limited disease in cosmetically sensitive areas.


Subject(s)
Glucocorticoids/administration & dosage , Lymphoma, B-Cell, Marginal Zone/drug therapy , Skin Neoplasms/drug therapy , Triamcinolone/administration & dosage , Cheek , Child , Humans , Injections, Intralesional , Lymphoma, B-Cell, Marginal Zone/diagnosis , Male , Remission Induction , Skin Neoplasms/diagnosis , Time Factors , Watchful Waiting
18.
Pediatr Dermatol ; 36(2): 227-231, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30840320

ABSTRACT

We report on four children born with medium to large congenital melanocytic nevi (CMN) with color heterogeneity and irregular surface rugosity. As these patients aged, their nevi evolved to become more homogeneous and lighter in color, and developed a smoother, more even texture. We propose that given this evolution toward benignity, conservative monitoring and management may be appropriate even in the context of atypical-appearing features at birth. Such knowledge regarding the evolution of these CMN can more accurately guide parents and clinicians in determining whether to biopsy or remove an atypical-looking lesion early in life for medical or cosmetic reasons.


Subject(s)
Nevus, Pigmented/pathology , Skin Neoplasms/pathology , Skin/pathology , Female , Humans , Infant , Male , Nevus, Pigmented/congenital , Skin Neoplasms/congenital
19.
Pediatr Dermatol ; 34(4): 486-487, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28523864

ABSTRACT

Methylisothiazolinone (MI) is an emerging and increasing cause of allergic contact dermatitis (ACD) in children. We present the case of a 7-year-old girl with an unusual dermatitis suspicious for contact allergy. Patch testing confirmed allergy to MI, found only in the patient's laundry detergent. This case highlights the importance of checking household product ingredients and the role of MI as an increasing cause of ACD in children.


Subject(s)
Dermatitis, Allergic Contact/etiology , Detergents/adverse effects , Thiazoles/immunology , Child , Dermatitis, Allergic Contact/drug therapy , Female , Glucocorticoids/therapeutic use , Humans , Patch Tests , Thiazoles/adverse effects , Triamcinolone/therapeutic use
20.
Pediatr Dermatol ; 33(1): 80-3, 2016.
Article in English | MEDLINE | ID: mdl-26758091

ABSTRACT

Allergic contact dermatitis (ACD) is common in children and adolescents. A history of persistent rash despite appropriate treatment should raise suspicion of ACD. We present the case of a 16-year-old boy with chronic dermatitis suspected of being a possible nickel allergy. He and his mother denied known common exposures. Patch testing confirmed allergies to multiple metals and several preservatives. A detailed social history revealed that the patient was an avid coin collector. Information about hobbies and activities should be elicited in any patient in whom ACD is suspected to determine exposures they may not initially have considered relevant. This case highlights the importance of pre- and posttest counseling and exposure history.


Subject(s)
Allergens , Dermatitis, Allergic Contact , Metals , Numismatics , Adolescent , Humans , Male , Allergens/adverse effects , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/etiology , Dermatitis, Allergic Contact/therapy , Glucocorticoids/therapeutic use , Metals/adverse effects , Patch Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...